Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ROSNER, Gary L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 34

  • Page / 2
Export

Selection :

  • and

Optimal sampling times in population pharmacokinetic studiesSTROUD, Jonathan R; MÜLLER, Peter; ROSNER, Gary L et al.Applied statistics. 2001, Vol 50, Num 3, pp 345-359, issn 0035-9254Article

Sojourn time and lead time projection in lung cancer screeningDONGFENG WU; ERWIN, Diane; ROSNER, Gary L et al.Lung cancer. 2011, Vol 72, Num 3, pp 322-326, issn 0169-5002, 5 p.Article

Randomized discontinuation design: Application to cytostatic antineoplastic agentsROSNER, Gary L; STADLER, Walter; RATAIN, Mark J et al.Journal of clinical oncology. 2002, Vol 20, Num 22, pp 4478-4484, issn 0732-183X, 7 p.Article

Estimating the Term Structure With a Semiparametric Bayesian Hierarchical Model: An Application to Corporate BondsCRUZ-MARCELO, Alejandro; ENSOR, Katherine B; ROSNER, Gary L et al.Journal of the American Statistical Association. 2011, Vol 106, Num 494, pp 387-395, issn 0162-1459, 9 p.Article

A nonparametric Bayesian model for inference in related longitudinal studiesMÜLLER, Peter; ROSNER, Gary L; DE LORIO, Maria et al.Applied statistics. 2005, Vol 54, pp 611-626, issn 0035-9254, 16 p., 3Article

An ANOVA model for dependent random measuresDE IORIO, Maria; MÜLLER, Peter; ROSNER, Gary L et al.Journal of the American Statistical Association. 2004, Vol 99, Num 465, pp 205-215, issn 0162-1459, 11 p.Article

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice GuidelineGRIGGS, Jennifer J; MANGU, Pamela B; SHAYNE, Michelle et al.Journal of clinical oncology. 2012, Vol 30, Num 13, pp 1553-1561, issn 0732-183X, 9 p.Article

Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients : a report from the children's oncology groupTHOMPSON, Patrick A; GUPTA, Manish; ROSNER, Gary L et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 6, pp 1027-1037, issn 0344-5704, 11 p.Article

A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between african-american and caucasian cancer patients : CALGB 9871LEWIS, Lionel D; MILLER, Antonius A; OTTERSON, Gregory A et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3302-3311, issn 1078-0432, 10 p.Article

Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network studyTHOMPSON, Patrick A; ROSNER, Gary L; MATTHAY, Katherine K et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 2, pp 243-251, issn 0344-5704, 9 p.Article

Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology : Cancer and leukemia group B (CALGB 9762)LICHTMAN, Stuart M; HOLLIS, Donna; PARISE, Robert A et al.Journal of clinical oncology. 2006, Vol 24, Num 12, pp 1846-1851, issn 0732-183X, 6 p.Article

Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and leukemia group B study 9763MILLER, Antonius A; ROSNER, Gary L; EGORIN, Merrill J et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8325-8331, issn 1078-0432, 7 p.Article

Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemiaRELLING, Mary V; WENJIAN YANG; KASTE, Sue C et al.Journal of clinical oncology. 2004, Vol 22, Num 19, pp 3930-3936, issn 0732-183X, 7 p.Article

Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphomaBASS, Adam J; GOCKERMAN, Jon P; RIZZIERI, David A et al.Journal of clinical oncology. 2002, Vol 20, Num 13, pp 2995-3000, issn 0732-183XArticle

Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemiaRIZZIERI, David A; BASS, Adam J; JACOBSON, Robert et al.Journal of clinical oncology. 2002, Vol 20, Num 3, pp 674-679, issn 0732-183XArticle

Fentanyl Does Not Reduce the Incidence of Laryngospasm in Children Anesthetized with SevofluraneERB, Thomas O; VON UNGERN-STERNBERG, Britta S; KELLER, Kathrin et al.Anesthesiology (Philadelphia). 2010, Vol 113, Num 1, pp 41-47, issn 0003-3022, 7 p.Article

Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia : a report from the Children's Oncology GroupDAVIES, Stella M; BOROWITZ, Michael J; DAS, Soma et al.Blood. 2008, Vol 111, Num 6, pp 2984-2990, issn 0006-4971, 7 p.Article

A phase i trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: Report of cancer and leukemia group B 9661FLEMING, Gini F; MEROPOL, Neal J; RATAIN, Mark J et al.Clinical cancer research. 2002, Vol 8, Num 12, pp 3718-3727, issn 1078-0432, 10 p.Article

A bayesian model for detecting acute change in nonlinear profilesMÜLLER, Peter; ROSNER, Gary L; INOUE, Lurdes Y. T et al.Journal of the American Statistical Association. 2001, Vol 96, Num 456, pp 1215-1222, issn 0162-1459Article

A semiparametric Bayesian model for repeatedly repeated binary outcomesQUINTANA, Fernando A; MÜLLER, Peter; ROSNER, Gary L et al.Applied statistics. 2008, Vol 57, Num 4, pp 419-431, issn 0035-9254, 13 p.Article

Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemiaHUI YANG; KADIA, Tapan; KANTARJIAN, Hagop M et al.Blood. 2009, Vol 113, Num 9, pp 1892-1898, issn 0006-4971, 7 p.Article

Ancestry and pharmacogenetics of antileukemic drug toxicityKISHI, Shinji; CHENG CHENG; PUI, Ching-Hon et al.Blood. 2007, Vol 109, Num 10, pp 4151-4157, issn 0006-4971, 7 p.Article

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemiaTHOMPSON, Patrick A; MURRY, Daryl J; ROSNER, Gary L et al.Cancer chemotherapy and pharmacology. 2007, Vol 59, Num 6, pp 847-853, issn 0344-5704, 7 p.Article

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinomaRATAIN, Mark J; EISEN, Tim; ROWINSKY, Eric et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2505-2512, issn 0732-183X, 8 p.Article

Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 geneWU, Michael H; PEIXIAN CHEN; XIAOLIN WU et al.Pharmacogenetics (London). 2004, Vol 14, Num 9, pp 595-605, issn 0960-314X, 11 p.Article

  • Page / 2